首页 › 基金 › Madison Avenue Partners, LP › RARE

Madison Avenue Partners, LP 对 RARE 的持仓历史

ULTRAGENYX PHARMACEUTICAL IN · 医疗保健

Madison Avenue Partners, LP 在 Q3 2026 的 13F 申报中披露持有 RARE(ULTRAGENYX PHARMACEUTICAL IN)1,705,351 股,市值约 US$25.6M,约占其申报组合的 1.02%,在其申报持仓中市值排名第 20 位。 Madison Avenue Partners, LP 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)1.71M 股
申报持仓市值$25.63M
组合权重1.02%
首次申报Q3 2026
最近变动新进
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Madison Avenue Partners, LP 对 RARE 的持仓演变

Madison Avenue Partners, LP 于 Q3 2026 首次披露 RARE 持仓:1,705,351 股(约 US$25.6M)。

逐季持仓明细

季度股数金额变化
Q3 2026 1.71M $25.63M 新进

关于 RARE 与 13F 数据

RARE(ULTRAGENYX PHARMACEUTICAL IN)属于医疗保健行业。我们追踪的基金中还有 21 只申报持有 RARE,申报仓位最大的包括:RTW INVESTMENTS, LP (US$128.2M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M), Bellevue Group AG (US$66.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RARE 的基金

查看 RARE 的全部基金持有人 →

常见问题

How long has Madison Avenue Partners, LP held RARE?

Madison Avenue Partners, LP has disclosed RARE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Madison Avenue Partners, LP's current position in RARE?

As of Q3 2026, Madison Avenue Partners, LP holds 1.71M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $25.63M, representing 1.02% of its reported portfolio and ranking #20.

Has Madison Avenue Partners, LP been buying or selling RARE?

In the latest 13F filing (Q3 2026), Madison Avenue Partners, LP newly opened its position in RARE.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, FRONTIER CAPITAL MANAGEMENT CO LLC, Bellevue Group AG, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.